Eli Lilly and Company (LLY) vs Oracle Corporation (ORCL)
See how Eli Lilly and Company and Oracle Corporation differ across market data and performance, so you can decide which asset best fits your strategy.
$1,179.11
NYSE
Eli Lilly & Co. is a pharmaceutical company focused on neuroscience, cardiometabolic disease, oncology, and immunology. Its leading products include Verzenio and Jaypirca in cancer treatment; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin in cardiometabolic care; and Taltz and Olumiant in immunology.
Oracle Corporation delivers enterprise applications and infrastructure solutions through flexible IT deployment models, including on-premises, cloud, and hybrid environments. Founded in 1977, Oracle introduced the first commercial SQL-based relational database management system, widely used by many of the world’s largest enterprises for high-volume online transaction processing. In addition to its database products, Oracle offers enterprise resource planning platforms and cloud infrastructure that are becoming increasingly important for large language model training and inference.